School of Medicine
Showing 1-10 of 24 Results
-
Amirsaman Ashtari
Postdoctoral Scholar, Radiation Biology
BioI am a postdoctoral researcher at Stanford University, jointly supervised by Ash Alizadeh MD/PhD and Mohammad Shahrokh Esfahani PhD. I developed several AI solutions for the Computer Vision and Computer Graphic domains during my PhD studies at KAIST and ETH Zurich. My PhD research outcome was recognized by winning the Young Researcher Award, and I was eager to apply all those AI techniques to biological data for cancer therapy. In the Alizadeh and Esfahani labs, I will develop AI solutions and computational tools to better understand the tumor microenvironment. Outside of my research, I enjoy loving my family, playing the piano, and listening to music.
-
Laura Attardi
Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics
Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
-
Richard Frock
Assistant Professor of Radiation Oncology (Radiation and Cancer Biology)
Current Research and Scholarly InterestsWe are a functional genomics laboratory interested in elucidating mechanisms of DNA repair pathway choice and genome instability. We use genome-wide repair fate maps of targeted DNA double strand breaks (DSBs) to develop pathway-specific models and combinatorial therapies. Our expertise overlaps many different fields including: genome editing, ionizing radiation, cancer therapeutics, V(D)J and IgH class switch recombination, repair during transcription and replication, and meiosis.
-
Amato J. Giaccia
Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
Current Research and Scholarly InterestsDuring the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.
-
Lu Ji
Postdoctoral Scholar, Radiation Biology
BioDriven by the enthusiasm and curiosity about life science and human disease, I have been working on cancer research for more than 5 years. I focus on developing novel therapeutic targets from tumor microenvironment and uncovering mechanisms of tumor progression, especially with expertise in gastrointestinal tumor biology and tumor microenvironment analysis. Now I'm digging into a field about finding a way to empower immunotherapy by appropriately utilizing radiation therapy.
-
Micah Kelly
Administrative Associate 3, Radiation Oncology - Radiation Biology
Current Role at StanfordAdministrative Associate to Drs. Erinn Rankin, Richard Frock, and Ted Graves
